Friday, May 24, 2013

City:Minneapolis

Barostim neo™

Minneapolis, United States

Barostim neo™ is the second-generation implantable device, from CVRx. In August 2011 they announced the launch of a clinical trial to evaluate Barostim therapy for the treatment of heart failure. The Barostim neo features a unilateral, 1mm electrode and a new smaller, more advanced generator to allow for more focused and efficient delivery of therapy, leading to shorter procedure ti ...
Read More...

Category:Pacemakers
ManufacturerCVRx
Hits590
Updated27 August 2011

Search The Catalog

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health HONcode standard for trustworthy health information: verify here.